Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
299
datasets available to search
ShareScore release 0.9.0
Dataset results
299 results for “Prognostic factors”
Dataset on prognostic factors in patients with metastatic castration-resistant prostate cancer undergoing radioligand therapy with [177Lu]Lu-PSMA-617
<p>This upload provides Open Data associated with the publication "Prognostic value of the De Ritis ratio for overall survival in patients with metastatic castration-resistant prostate cancer undergoing [<sup>177</sup>Lu]Lu-PSMA-617 radioligand therapy" by Gaal S <em>et al.</em> (2023).</p> <p>The upload contains the anonymized dataset of 91 patients analyzed in this publication with all variables that are required to reproduce the results.</p> <p>However, to fully comply with requirements for data anonymization, the patients' age was categorized into groups spanning 5 years each. A dataset with the age variable in exact years can be obtained from the corresponding author (julian.rogasch@charite.de) upon reasonable request.</p> <p>Besides the dataset, this upload provides a dictionary to explain all variables and their categories.</p>
Trial of Prognostic Factors and Surgical Methods for the Treatment of Idiopathic Macular Holes
ClinicalTrials.gov study NCT00302328. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Treatments for Brain Metastases With Poor Prognostic Factors
ClinicalTrials.gov study NCT05609162. IPD Sharing: NO. Countries: 1. Publications: 1.
Overweight and Obesity as Prognostic Factors for Survival in Children With Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT04271215. IPD Sharing: NO. Countries: 1. Publications: 1.
Severe Acquired Brain Injuries: Prognostic Factors and Quality of Care
ClinicalTrials.gov study NCT04905264. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve
ClinicalTrials.gov study NCT02394834. IPD Sharing: YES. Countries: 1. Publications: 2.
Identifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00759798. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Aetiology and prognostic risk factors of mortality in pneumonia patients receiving glucocorticoids alone or glucocorticoids and other immunosuppressants: a retrospective cohort study
<p><b>Objectives:</b> Long-term use of high-dose glucocorticoids can lead to severe immunosuppression and increased risk of treatment-resistant pneumonia and mortality. We investigated the aetiology and prognostic risk factors of mortality in hospitalised patients who developed pneumonia while receiving glucocorticoid therapy alone or glucocorticoid and other immunosuppressant therapies.</p> <p><b>Design:</b> Retrospective cohort study</p> <p><b>Setting: </b>Six secondary and tertiary academic hospitals in China</p> <p><b>Participants: </b>Patients receiving glucocorticoids who were hospitalised with pneumonia between 1<sup>st</sup> January 2013 and 31<sup>st</sup> December 2019.</p> <p><b>Main Outcomes: </b>We analysed<b> </b>the prevalence of comorbidities, microbiology, antibiotic susceptibility patterns, 30-day and 90-day mortality rates, and prognostic risk factors.</p> <p><b>Results</b>: A total of 716 patients were included, with pneumonia pathogens identified in 69.8% of patients. Significant morbidities occurred, including respiratory failure (50.8%), intensive care unit (ICU) transfer (40.8%), and mechanical ventilation (36%), with a 90-day mortality rate of 26.0%. Diagnosis of pneumonia occurred within 6 months of glucocorticoid initiation for 69.7% of patients with <i>Cytomegalovirus</i> (CMV) pneumonia and 79.0% of patients with <i>Pneumocystis jirovecii</i> pneumonia (PCP). Pathogens, including <i>Pneumocystis</i>, CMV, and multidrug-resistant bacteria, were identified more frequently in patients with persistent lymphocytopenia and high-dose glucocorticoid treatment (≥ 30 mg/day of prednisolone or equivalent within 30 days before admission). The 90-day mortality rate was significantly lower for non-CMV viral pneumonias than for PCP (<i>P</i> < 0.05), with a similar mortality rate as CMV pneumonias (24.2% vs 38.1% vs 27.4%, respectively).Cox regression analysis indicated <a name="_Hlk30339725"></a><a name="_Hlk31278800">several independent negative predictors for mortality in this patient population, including septic shock, respiratory failure, </a>persistent lymphocytopenia, interstitial lung disease, and high-dose glucocorticoid use.</p> <p><b>Conclusions</b>: Patients who developed pneumonia while receiving glucocorticoid therapy experienced high rates of opportunistic infections, with significant morbidity and mortality. These findings should be carefully considered when determining treatment strategies for this patient population.</p>
Dataset : Acute kidney injury complicating critical forms of COVID-19: risk factors and prognostic impact
<p><span><span>We aimed to assess the incidence, risk factors and prognostic impact of AKI complicating critical forms of COVID-19. Thus we conducted a</span> retrospective descriptive case/control monocentric study conducted in a medical intensive care unit of a tertiary teaching hospital over a period of 18 months.</span></p>
Etiology and Prognostic Risk Factors of Intracerebral Hemorrhage in Beijing
ClinicalTrials.gov study NCT02350010. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Survival and Prognostic Factors of Squamous Cell Carcinoma of the Nasal Vestibule
ClinicalTrials.gov study NCT05693116. IPD Sharing: NO. Countries: 3. Publications: 3.
Outcome and Prognostic Factors of Surgical Management of Scalp AVMs.
ClinicalTrials.gov study NCT05341336. IPD Sharing: NO. Countries: 1. Publications: 9.
Study of COVID-19 Prognostic Factors in Hospitalized Patients
ClinicalTrials.gov study NCT05102708. IPD Sharing: UNDECIDED. Countries: 1. Publications: 20.
Procalcitonin at Zero and 24 Hours as a Prognostic Factor in Patients With Pneumonia
ClinicalTrials.gov study NCT03711227. IPD Sharing: NO. Countries: 1. Publications: 22.
Prognostic Factors for Complex Regional Pain Syndrome
ClinicalTrials.gov study NCT05337501. IPD Sharing: NO. Countries: 1. Publications: 6.
Long-term Outcomes and Prognostic Factors in Patient Undergoing CABG or PCI
ClinicalTrials.gov study NCT03870815. IPD Sharing: Not stated. Countries: 1. Publications: 8.
Prognostic Factors of Escherichia Coli Bloodstream Infections: Severity Score and Therapeutic Implications
ClinicalTrials.gov study NCT02890901. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
The Clinicopathological and Prognostic Factors of Hepatocellular Carcinoma; 10 Years' Tertiary Center Experience in Egypt
ClinicalTrials.gov study NCT05047146. IPD Sharing: YES. Countries: 1. Publications: 1.
Study of Heat Shock Proteins as Prognostic Factor of Acute Renal Failure in Children (HSP-Study)
ClinicalTrials.gov study NCT00230412. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Evaluation of Prognostic Factors: From Breast Cancer to Bone Metastases
ClinicalTrials.gov study NCT04167605. IPD Sharing: NO. Countries: 1. Publications: 6.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.